Clinical Trials Browser

Familial ependymoma, Uveal Melanoma, Astrocytoma, Brain Neoplasms, Chondrosarcoma, Ependymoma, Glioblastoma, Glioma, Lung Neoplasms, Medulloblastoma, Melanoma, Neoplasm Metastasis, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Glioma, Subependymal, Gliosarcoma, Rhabdoid Tumor, Optic Nerve Glioma, Small Cell Lung Carcinoma, Desmoplastic Small Round Cell Tumor

NCT03705351 2024-03-04

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Phase 1 Terminated

7 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT01811498 2024-01-30

Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM

Phase 1/2 Completed

31 enrolled 7 charts

CNS

Brain Neoplasms, Glioblastoma

NCT01383135 2024-01-12

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2

Phase EARLY_PHASE1 Completed

27 enrolled 14 charts

BreastCNSThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma

Clinical Trials

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

2-THE-TOP

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

NeoGlio

Infigratinib in Recurrent High-Grade Glioma Patients

JAZZ

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

M032-HSV-1

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

A Study of Abemaciclib in Recurrent Glioblastoma

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

C134-HSV-1

HUMC 1612: Optune NovoTTF-200A System

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Temozolomide Chronotherapy for High Grade Glioma

VB-111 in Surgically Accessible Recurrent/Progressive GBM

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

OU-SCC-PI-4G

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

ATTAC-II

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

BRAF

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

I-ATTAC

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2